These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21502040)

  • 1. Animal cell substrates: back to the future.
    Petricciani J
    PDA J Pharm Sci Technol; 2010; 64(5):375-8. PubMed ID: 21502040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell substrates: where do we stand after 50 years of discussion?
    Petricciani J
    Dev Biol (Basel); 2006; 123():11-21; discussion 55-73. PubMed ID: 16566432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of animal cell substrates for biological products.
    Petricciani J; Sheets R
    Biologicals; 2008 Nov; 36(6):359-62. PubMed ID: 18674929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory philosophy and acceptability of cells for the production of biologicals.
    Petricciani JC
    Dev Biol Stand; 1991; 75():9-15. PubMed ID: 1794634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals: application to influenza vaccine production.
    Griffiths E
    Dev Biol Stand; 1999; 98():153-7; discussion 167. PubMed ID: 10494968
    [No Abstract]   [Full Text] [Related]  

  • 6. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.
    Barrett PN; Mundt W; Kistner O; Howard MK
    Expert Rev Vaccines; 2009 May; 8(5):607-18. PubMed ID: 19397417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of cell culture-based influenza vaccine production.
    Perdue ML; Arnold F; Li S; Donabedian A; Cioce V; Warf T; Huebner R
    Expert Rev Vaccines; 2011 Aug; 10(8):1183-94. PubMed ID: 21854311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement of animals in manufacture and control of vaccines.
    Hennessen W
    Dev Biol Stand; 1980; 45():163-73. PubMed ID: 6772505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell substrates: lessons learned and challenges remaining.
    Petricciani JC
    Dev Biol Stand; 1999; 100():57-63. PubMed ID: 10616176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational research on vaccines: influenza as an example.
    Belshe RB
    Clin Pharmacol Ther; 2007 Dec; 82(6):745-9. PubMed ID: 17971813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From brain passage to cell adaptation: the road of human rabies vaccine development.
    Wu X; Smith TG; Rupprecht CE
    Expert Rev Vaccines; 2011 Nov; 10(11):1597-608. PubMed ID: 22043958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell substrates for the production of viral vaccines.
    Aubrit F; Perugi F; Léon A; Guéhenneux F; Champion-Arnaud P; Lahmar M; Schwamborn K
    Vaccine; 2015 Nov; 33(44):5905-12. PubMed ID: 26187258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Karyology and tumorigenicity testing requirements: past, present and future.
    Petricciani JC; Horaud FN
    Dev Biol Stand; 1998; 93():5-13. PubMed ID: 9737371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality assurance for cell substrates.
    Stacey GN; Phillips P
    Dev Biol Stand; 1999; 98():141-51; discussion 167. PubMed ID: 10494967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cultural influenza vaccines].
    Gendon IuZ
    Vopr Virusol; 2002; 47(6):4-11. PubMed ID: 12508674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral safety of biological products in WHO policy.
    Grachev VP
    Dev Biol Stand; 1991; 75():241-6. PubMed ID: 1794628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine viral diarrhea virus contamination of nutrient serum, cell cultures and viral vaccines.
    Levings RL; Wessman SJ
    Dev Biol Stand; 1991; 75():177-81. PubMed ID: 1665461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines.
    Hess RD; Weber F; Watson K; Schmitt S
    Vaccine; 2012 Apr; 30(17):2715-27. PubMed ID: 22342707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of live attenuated influenza vaccines against pandemic influenza strains.
    Coelingh KL; Luke CJ; Jin H; Talaat KR
    Expert Rev Vaccines; 2014 Jul; 13(7):855-71. PubMed ID: 24867587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.